|
presumptive paraxial mesoderm
|
UBERON_0007285 |
[The part of the blastula that has the potential to develop into a paraxial mesoderm.] |
|
Elevated aortic transvalvular pressure gradient
|
HP_6000226 |
[The gradient (in this case, drop) in pressure across the aortic valve is above the upper limit of normal.] |
|
Abnormal aortic physiology
|
HP_0030964 |
|
|
Single second heart sound
|
HP_6000225 |
[The second sound can remain single throughout the respiratory cycle due to either absence of one component or to synchronous occurrence of the two components. Since the pulmonary vascular impedance increases with age, many normal patients over age 50 have a single S2 or at most a narrow physiologic split on inspiration because P2 occurs early. A single second sound, however, is usually due to inability to auscultate a relatively soft pulmonic component. Such inability is rare in healthy infants, children, and young adults and is uncommon even in older persons under good auscultatory conditions using a rigid stethoscopic diaphragm.] |
|
Abnormal second heart sound
|
HP_0031661 |
[Any anomaly of the second heart sound (S2), which is produced by aortic (A2) and pulmonic (P2) valve closure. The A2-P2 interval normally increases with inspiration and narrows with expiration.] |
|
Failure to increase oxygen saturation on hyperoxia test
|
HP_6000228 |
[Hyperoxia test is the initial method to distinguish critical congenital heart disease (CCHD) from pulmonary disease. The test consists in measuring an arterial blood gas at room air and 100% inspired oxygen after 10 minutes. Neonates with congenital heart disease are usually not able to increase PaO2 above 100 mm Hg during 100% oxygen administration. In patients with pulmonary disease, PaO2 generally increased greater than or equal to 100 mm Hg with 100% oxygen as ventilation-perfusion discrepancies are overcome. A positive result indicates the cardiac origin and further cardiac workup is indicated to rule out CCHD.] |
|
presumptive neural plate
|
UBERON_0007284 |
[A presumptive structure that has the potential to develop into a neural plate.] |
|
future central nervous system
|
UBERON_0016879 |
[Primordium that develops into the central nervous system.] |
|
Prosthetic heart valve
|
HP_6000227 |
[A past surgical history of the implanation of an artificial heart valve.] |
|
Partial hyposmia
|
HP_0010635 |
[Reduced ability to perceive certain odorants (implies that the sense of smell is maintained for other classes of odorants).] |
|
Hyposmia
|
HP_0004409 |
[A decreased sensitivity to odorants (that is, a decreased ability to perceive odors).] |
|
Decreased circulating apolipoprotein A-II concentration
|
HP_0034602 |
[Concentration of apolipoprotein A-II below the lower limit of normal.] |
|
Elevated circulating CA19-9 concentration
|
HP_0034603 |
[The concentration of CA19-9 (= carbohydrate antigen 19-9) in the blood circulation is above the upper limit of normal.] |
|
Schizencephaly
|
HP_0010636 |
[The presence of a cleft in the cerebral cortex unilaterally or bilaterally, usually located in the frontal area.] |
|
High-set nipples
|
HP_6000229 |
[Placement of the nipples at a higher than normal location.] |
|
gonadorelin
|
CHEBI_5520 |
[A ten-membered synthetic oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, glycyl, leucyl, arginyl, prolyl and glycinamide residues joined in sequence.] |
|
oligopeptide
|
CHEBI_25676 |
[A peptide containing a relatively small number of amino acids.] |
|
Partial anosmia
|
HP_0010633 |
[Inability to perceive certain odorants (implies that the sense of smell is maintained for other classes of odorants).] |
|
Elevated circulating DOPA concentration
|
HP_0034604 |
[Concentration of DOPA (3,4-dihydroxyphenylalanine) in the blood circulation above the upper limit of normal.] |
|
Abnormal circulating monocarboxylic acid concentration
|
HP_0010996 |
[Any deviation from the normal concentration of a monocarboxylic acid in the blood circulation.] |